CN102766139B - 阿齐沙坦的多晶型物及其制备方法 - Google Patents
阿齐沙坦的多晶型物及其制备方法 Download PDFInfo
- Publication number
- CN102766139B CN102766139B CN201210288384.2A CN201210288384A CN102766139B CN 102766139 B CN102766139 B CN 102766139B CN 201210288384 A CN201210288384 A CN 201210288384A CN 102766139 B CN102766139 B CN 102766139B
- Authority
- CN
- China
- Prior art keywords
- azilsartan
- polymorphic
- preparation
- solid
- polymorphic form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210288384.2A CN102766139B (zh) | 2012-08-14 | 2012-08-14 | 阿齐沙坦的多晶型物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210288384.2A CN102766139B (zh) | 2012-08-14 | 2012-08-14 | 阿齐沙坦的多晶型物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102766139A CN102766139A (zh) | 2012-11-07 |
CN102766139B true CN102766139B (zh) | 2014-09-17 |
Family
ID=47093747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210288384.2A Active CN102766139B (zh) | 2012-08-14 | 2012-08-14 | 阿齐沙坦的多晶型物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102766139B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103930419B (zh) * | 2011-09-30 | 2016-06-01 | 广东东阳光药业有限公司 | 阿齐沙坦的晶型及其制备方法 |
CN103044412B (zh) * | 2012-12-26 | 2016-04-06 | 华润赛科药业有限责任公司 | 一种阿齐沙坦的多晶型及其制备方法 |
CN103319473A (zh) * | 2013-07-02 | 2013-09-25 | 合肥医工医药有限公司 | 阿齐沙坦的多晶型及其制备方法 |
CN103360381B (zh) * | 2013-07-30 | 2015-10-28 | 山东新华制药股份有限公司 | 阿齐沙坦的新晶型及其制备方法和应用 |
CN104341408A (zh) * | 2013-08-02 | 2015-02-11 | 江苏柯菲平医药股份有限公司 | 一种阿奇沙坦的新晶型及其制备方法 |
CN104262334A (zh) * | 2014-09-16 | 2015-01-07 | 常州大学 | 一种阿奇沙坦晶体及其制备方法 |
CN104557899B (zh) * | 2014-11-17 | 2018-05-22 | 江苏中邦制药有限公司 | 一种阿齐沙坦i晶型晶体的制备方法 |
CN106749216B (zh) * | 2016-12-30 | 2021-05-04 | 湖南千金湘江药业股份有限公司 | 一种晶型a阿齐沙坦的精制方法 |
WO2019155922A1 (ja) * | 2018-02-09 | 2019-08-15 | 株式会社トクヤマ | アジルサルタンa型結晶の製造方法 |
CN108912109A (zh) * | 2018-08-17 | 2018-11-30 | 珠海润都制药股份有限公司 | 一种高纯度、小粒径及低溶剂残留的阿齐沙坦原料药及其制备方法 |
CN110041320B (zh) * | 2019-04-24 | 2020-11-20 | 浙江天宇药业股份有限公司 | 一种阿齐沙坦的结晶的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW251288B (zh) * | 1991-06-27 | 1995-07-11 | Takeda Dharm Industry Co Ltd | |
DE60008262T2 (de) * | 1999-09-25 | 2004-12-16 | Smithkline Beecham P.L.C., Brentford | Piperazinderivate als 5-ht1b antagonisten |
CN102827153B (zh) * | 2011-06-14 | 2016-10-05 | 江苏豪森药业集团有限公司 | 阿齐沙坦的晶型及其制备方法 |
-
2012
- 2012-08-14 CN CN201210288384.2A patent/CN102766139B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102766139A (zh) | 2012-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102766139B (zh) | 阿齐沙坦的多晶型物及其制备方法 | |
KR102075371B1 (ko) | 퀴놀린 유도체 제조 방법 | |
CN102985416B (zh) | 制备凝血酶特异性抑制剂的方法 | |
JP6170146B2 (ja) | チロシンキナーゼ阻害剤二マレイン酸塩のi型結晶およびその製造法 | |
US20180170958A1 (en) | Crystalline form a of obeticholic acid and preparation method thereof | |
EP2612855A1 (en) | Novel crystal of erlotinib base and the preparation method thereof | |
CN104736540B (zh) | 培美曲塞及其赖氨酸盐的制备方法 | |
WO2015037016A2 (en) | An improved process for the preparation of ticagrelor and intermediates thereof | |
CN103664922A (zh) | 新晶型阿齐沙坦及其制备方法 | |
CN104030989A (zh) | 一种瑞舒伐他汀钙的制备方法 | |
CN102321073A (zh) | 一种尼罗替尼的制备方法 | |
US10654876B2 (en) | TH-302 solid forms and methods related thereto | |
CN105793263A (zh) | 反式-8-氯-5-甲基-1-[4-(吡啶-2-基氧基)-环己基]-5,6-二氢-4h-2,3,5,10b-四氮杂-苯并[e]薁及其晶型的合成 | |
RU2736722C2 (ru) | Способ получения соединения пиразоламида | |
CN103012300A (zh) | 一种制备缬沙坦的新方法 | |
CN104844549A (zh) | 一种7-溴吡喃衍生物的制备方法 | |
CN103554049A (zh) | 一种制备缬沙坦的方法 | |
CN104744464A (zh) | 伊曲茶碱晶型 | |
EP2598485B1 (en) | Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same | |
CN104817482A (zh) | 2-取代吡咯烷类化合物、制备方法及其在制备维格列汀中的应用 | |
CN104292213A (zh) | 一种嘧啶衍生物的制备方法 | |
CN106083822B (zh) | 一种甲磺酸达比加群酯中间体的制备方法 | |
CN105175490A (zh) | 一种制备阿加曲班中间体的方法 | |
CN104725349A (zh) | 阿格列汀盐酸盐多晶a型晶体、其制备方法及生产用途 | |
CN104130245A (zh) | 盐酸帕唑帕尼n晶型及其制备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU SIMCERE PHARMACEUTICAL CO., LTD. Effective date: 20150624 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150624 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160728 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |